Bill

Bill > HB927


LA HB927

LA HB927
Provides relative to the Medicaid Pharmaceutical and Therapeutics Committee


summary

Introduced
02/27/2026
In Committee
03/09/2026
Crossed Over
Passed
Dead

Introduced Session

2026 Regular Session

Bill Summary

AN ACT To amend and reenact R.S. 46:153.3, to enact R.S. 46:153.3(D)(2)(a)(xii), and to repeal R.S. 46:153.3(C)(1), relative to the Medicaid Pharmaceutical and Therapeutics Committee; to provide for changes in the committee's composition; to provide for the removal of certain restrictions related to HIV/AIDS medications; and to provide for related matters.

AI Summary

This bill modifies the composition of the Medicaid Pharmaceutical and Therapeutics Committee, which is responsible for reviewing and making recommendations on medications covered by Medicaid, a government health insurance program for low-income individuals. Specifically, it removes a previous restriction related to HIV/AIDS medications and adds one physician or pharmacist from each Medicaid managed care organization to the committee, thereby changing the committee's membership. The bill also repeals a specific provision within the existing law concerning the committee's operations.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

House Committee on Health and Welfare (09:00:00 4/1/2026 Room 5) (on 04/01/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...